BERKELEY HEIGHTS, NJ, June 21, 2001
- Genta Incorporated (Nasdaq: GNTA) announced the election of Betsy
McCaughey, Ph.D., former New York State Lieutenant Governor, to its
Board of Directors.
Dr. McCaughey has had a distinguished career as a scholar and
politician, and she is a nationally recognized expert on health
care. Dr. McCaughey has had a distinguished academic career as a
faculty member at Columbia University and as John M. Olin Fellow at
the Manhattan Institute. In the mid 1990s, she received broad
recognition for her analysis of the Clinton health care plan. In
1995, she was elected as Lieutenant Governor of New York, and was a
candidate for Governor in 1998. As Lieutenant Governor, she drafted
legislation dealing with Medicaid reform, clinical trials access,
hospital financing, and insurance reform. She is currently an
Adjunct Senior Fellow at the Hudson Institute and is a frequent
commentator on the future of the health care industry. Dr.
McCaughey has authored numerous articles on health insurance,
medical innovation, government regulation and public policy, which
have appeared in publications such as The Wall Street Journal, New
Republic, The New York Times, and U.S. News and World Report. She
holds a B.A. from Vassar College and a M.A. and Ph.D. from Columbia
University.
"Dr. McCaughey brings enormous experience in health care policy
and legislation. She has a special interest in reimbursement for
pharmaceutical products, which is an area of very high interest for
Genta as we look forward to the launch of our Genasense
TM
product," said Dr. Raymond P. Warrell, Jr., Gentas Chairman
of the Board and Chief Executive Officer. "We are extremely pleased
to have someone with Betsys credentials add her expertise to these
key areas of our Board."
Dr. McCaughey noted: "Medical innovation is the key ingredient
to help our society relieve suffering from cancer and other
terrible diseases and meet the challenge of a rapidly aging
population. Genta is an innovator, and I am looking forward to
being closely involved with the search for effective cancer
treatments. I am pleased to contribute my assistance to the
Board."
